Log in to save to my catalogue

Oblique Therapeutics announces achievement of key milestone in its aKRAS-mAb program and Abiprot® pl...

Oblique Therapeutics announces achievement of key milestone in its aKRAS-mAb program and Abiprot® pl...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2576763053

Oblique Therapeutics announces achievement of key milestone in its aKRAS-mAb program and Abiprot® platform

About this item

Full title

Oblique Therapeutics announces achievement of key milestone in its aKRAS-mAb program and Abiprot® platform

Publisher

New York: PR Newswire Association LLC

Journal title

PR Newswire, 2021

Language

English

Publication information

Publisher

New York: PR Newswire Association LLC

More information

Alternative Titles

Full title

Oblique Therapeutics announces achievement of key milestone in its aKRAS-mAb program and Abiprot® platform

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_2576763053

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2576763053

How to access this item